The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

All entries were placed in a draw for one free registration to the TCT meeting and two Platinum memberships for TCTMD.

The agency is proposing that device manufacturers improve their testing to including larger, more diverse sample sizes.